Archive

This is the third edition of the South African Health Products Regulatory Authority’s (SAHPRA’s) ReguLetter that will provide a quarterly overview of regulatory decisions relating to safety alerts, recalls and rapid alerts. This edition will provide information for the period October to December 2025....

This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Jul - Sep 2024. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...

This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Oct - Dec 2024. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...

This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Apr - Jun 2025. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...

This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Jan - Mar 2025. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...

The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....

This document provides an overview of the medicines safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during January – March 2024. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...

This document provides an overview of the medicines safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during October – December 2023. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...